Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 373.5 JPY -1.72% Market Closed
Market Cap: 560.6B JPY

Intrinsic Value

The intrinsic value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is 3 091.65 JPY. Compared to the current market price of 2 373.5 JPY, Rohto Pharmaceutical Co Ltd is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
3 091.65 JPY
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Rohto Pharmaceutical Co Ltd

Rohto Pharmaceutical Co Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for Rohto Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Rohto Pharmaceutical Co Ltd
TSE:4527
JP
Consumer products
Market Cap
541.5B JPY
IPO
Oct 2, 1961
JP
Consumer products
Market Cap
541.5B JPY
IPO
Oct 2, 1961
Price
ÂĄfalse
EPS
ÂĄfalse
Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Rohto Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Rohto Pharmaceutical Co Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rohto Pharmaceutical Co Ltd

Current Assets 205.4B
Cash & Short-Term Investments 61.7B
Receivables 73.9B
Other Current Assets 69.9B
Non-Current Assets 198.4B
Long-Term Investments 48.1B
PP&E 86.8B
Intangibles 54.6B
Other Non-Current Assets 9B
Efficiency

Free Cash Flow Analysis
Rohto Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rohto Pharmaceutical Co Ltd

Revenue
295.6B JPY
Cost of Revenue
-126.7B JPY
Gross Profit
168.9B JPY
Operating Expenses
-131.8B JPY
Operating Income
37.1B JPY
Other Expenses
-7.5B JPY
Net Income
29.6B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Rohto Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
58/100
Profitability
Score

Rohto Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Rohto Pharmaceutical Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

88/100
Solvency
Score

Rohto Pharmaceutical Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Rohto Pharmaceutical Co Ltd

Wall Street analysts forecast Rohto Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Rohto Pharmaceutical Co Ltd is 3 308.2 JPY with a low forecast of 1 969.5 JPY and a high forecast of 4 263 JPY.

Lowest
Price Target
1 969.5 JPY
17% Downside
Average
Price Target
3 308.2 JPY
39% Upside
Highest
Price Target
4 263 JPY
80% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Rohto Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one Rohto Pharmaceutical Co Ltd stock?

The intrinsic value of one Rohto Pharmaceutical Co Ltd stock under the Base Case scenario is 3 091.65 JPY.

Is Rohto Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2 373.5 JPY, Rohto Pharmaceutical Co Ltd is Undervalued by 23%.

Back to Top